Format

Send to

Choose Destination
Cell Cycle. 2006 Apr;5(7):709-13. Epub 2006 Apr 1.

The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53.

Author information

1
Department of Oncological Sciences, Mount Sinai School of Medicine, New York, New York 10029, USA.

Abstract

The cdc25C gene has been shown to be a novel target for transcriptional downregulation by p53. Two independent mechanisms contribute to the p53-dependent repression of the cdc25C gene. First, an element in the cdc25C promoter consisting of a binding site for p53 plus an adjacent 8 base pairs confers p53-dependent repression. Mutation of either the p53 binding site or the adjacent 8 bp sequence abolishes this effect. The element conferring p53-dependent repression also contains a binding site for the transcription factor Sp1 and a mutant p53 protein that retains the ability to interact with the p53-binding site is defective in mediating repression. Second, a minimal promoter lacking the p53 binding site but containing a previously characterized CDE/CHR element is also repressed by p53. This repression is abrogated when a 5 bp mutation is introduced in the CHR sequence. These results support a model for p53 downregulating cdc25C expression, in part, by direct binding to a promoter element that is likely to require cooperation with an additional cellular factor.

PMID:
16582636
DOI:
10.4161/cc.5.7.2628
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center